By Maggie Fick and Jennifer Rigby LONDON (Reuters) -Drugmakers Bharat Biotech and GSK will cut the price of their malaria vaccine to below $5 per dose by 2028, more than halving its current cost, they ...

The vaccine being delivered in Cameroon is known as RTS,S, or Mosquirix, and is made by GSK. Another malaria vaccine, called R21, was developed by University of Oxford researchers and is being ...

As part of a multi-year collaboration, GSK and India’s Bharat Biotech are redoubling their efforts to bring the world’s first malaria vaccine to more countries in need at affordable prices.

Bharat Biotech and GSK to reduce price of malaria vaccine for children to less than USD 5 by 2028. The collaboration, supported by Gavi and WHO, aims to protect at least 50 million more children ...

In a recent development, Bharat Biotech and GSK announced a price reduction of $5, which aims to improve access and save thousands of children who suffer from malaria.

GSK’s malaria vaccine—RTS,S or Mosquirix—was celebrated as a major public health milestone in 2021 when it became the first ever shot to get the green light for widespread use in children ...

The article said that "in 2021, WHO endorsed the first malaria vaccine, known as Mosquirix, made by GSK. But that vaccine requires four doses and protection fades within months.

The malaria vaccine needed this sign-off, and since the European agency, a stringent regulator, had approved it, GSK and PATH assumed the W.H.O. would do so swiftly, too.

The introduction of the World Health Organization (WHO)-approved R21 vaccine comes six months after the first malaria vaccine, called RTS,S and developed by British drugmaker GSK, began being ...

Drugmakers Bharat Biotech and GSK will cut the price of their malaria vaccine to below $5 per dose by 2028, more than halving its current cost, they said on Wednesday.

LONDON (Reuters) -Drugmakers Bharat Biotech and GSK will cut the price of their malaria vaccine to below $5 per dose by 2028, more than halving its current cost, they said on Wednesday. The vaccine, ...